Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: Interactions with dopamine receptors of mammalian forebrain in vitro
- 3 October 1980
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 67 (1), 105-110
- https://doi.org/10.1016/0014-2999(80)90015-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanismsJournal of Pharmacy and Pharmacology, 1980
- (−)N-(Chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor bindingNature, 1980
- Aporphines. 30. (-)-N-(2-Chloroethyl)-10,11-dihydroxynoraporphine (chloroethylnorapomorphine), novel irreversible dopamine receptor antagonistJournal of Medicinal Chemistry, 1980
- Evidence for two types of binding of 3HGABA and 3Hmuccimol in rat cerebral cortex and cerebelumLife Sciences, 1979
- Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptorsEuropean Journal of Pharmacology, 1979
- Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamineEuropean Journal of Pharmacology, 1978
- Hydrolysis of diester prodrugs of apomorphineBiochemical Pharmacology, 1977
- Apomorphine: Chemistry, Pharmacology, BiochemistryPublished by Elsevier ,1976
- Dopamine Receptors in the BrainScience, 1975